期刊文献+

NT-proBNP、Hcy诊断急性冠脉综合征的临床研究 被引量:5

The study of N-terminal pro-brain natriuretic peptide and homocysteine in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨NT—proBNP、Hcy诊断急性冠脉综合征(ACS)的临床意义。方法对70例AMI患者、50例UAP患者、50例SAP患者和50例健康体检者的血浆NT—proBNP、Hey水平进行比较分析。ACS患者均行冠状动脉造影术,并对其病变程度进行评估。结果AMI组和UAP组患者血浆NT—proBNP水平显著高于SAP组及对照组(P〈0.05),而SAP组与对照组比较差异无统计学意义(P〉0.05);ACS组、SAP组血浆Hcy水平均高于对照组,各组间比较差异有统计学意义(P〈O.05)。随着冠脉病变支数增加,ACS患者血浆NT—proBNP、Hcy水平逐渐升高(P〈0.05)。ACS患者中,心血管事件组血浆NT—proBNP、Hcy水平明显高于无心血管事件组(p〈0.05)。结论急性冠脉综合征患者的血浆NT—proBNP、Hcy水平均与冠状动脉粥样化病变程度密切相关,是ACS心血管不良事件的预测因子。 Objective To discuss the clinical significance of N-terminal pro-brain natriuretic peptide and homocysteine in patients with acute coronary syndrome. Methods The plasma N-terminal pro-brain natriuretic peptide and homocysteine were measured with in 70 patients with acute myocardial infrction,50 patients with un- stable angina pectoris,50 patients with stable angina pectofisand and 50 normal medical persons. All the patients received the coronary angiography,and were evaluated severity of coronary atherosclerosis. Results The plasma N-terminal pro-brain natriuretic peptide levels in all the patients with acute coronary syndrome were significantly hingher than those of patients with stable angina pectofisand and the control group (P〈0.05). While the difference was not statistically significant in stable angina pectofisand group and the control group (P〉0.05).The plasma ho- mocysteine levels in all the patients with acute coronary syndrome and stable angina pectofisand are higher than the control group, each group is significant difference (P〈0.05).The plasma N-terminal pro-braln natriuretic pep- tide and homoeysteine levels in all the patients with acute coronary syndrome were increased with the increasing severity of coronary atherosclerosis (P〈0.05). In acute coronary syndrome patients,the NT-proBNP and homocys- teine levels with major adverse cardiac events group were significantly hingher than those of patients without major adverse cardiac events group. Conclusion The plasma N-terminal pro-brain natriuretic peptide and homocysteine levels in all the patients with acute coronary syndrome were closely correlated to the degree of coronary atheroma pathological damage, and were the acute coronary syndrome patients's major adverse cardiac events predictors.
出处 《中国心血管病研究》 CAS 2013年第8期604-607,共4页 Chinese Journal of Cardiovascular Research
关键词 N端脑钠肽前体 同型半胱氨酸 急性冠脉综合征 N-terminal pro-brain natriuretic peptide Homocysteine Acute coronary syndrome
  • 相关文献

参考文献10

  • 1Galvani M,Ottani F,Oltrona L,et al. N-terminal pro-Brain na-triuretic peptide on admission has prognostic value across thewhole spectrum of acute coronary syndromes. Circulation, 2004,110:128-134.
  • 2Marosi K, Agota A, V^gh V,et al. The role of homocysteine andmethylenetetrahydrofolate reductase, methionine synthase, me -thionine synthase reductase polymorphisms in the development ofcardiovascular diseases and hypertension. Orv Hetil,2012,153:445-453.
  • 3秦明照,陈一文,耿小勇.从最新临床生化指南看肌钙蛋白和脑钠肽在急性冠状动脉综合征中的地位[J].中华老年心脑血管病杂志,2007,9(11):782-783. 被引量:13
  • 4MoritaE,Yasue H,Yoshimura M,et al.Increased plasma levels ofbrain natriuretic peptide in patients with acute myocardialinfarc-tion. Circulation, 1993,88 ; 82-91.
  • 5Bonaca MP, Wiviott SD, Sabatine MS, et al. Hemodynamic sig-nificance of periprocedural myocardial injury assessed with N -terminal pro-B-type natriuretic peptide after percutaneous coro-nary intervention in patients with stable and unstable coronaryartery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol,2007, 99:344-348.
  • 6DeLemos JA. Morrow DA,Bentley JH,et al.The prognostic valueof B—type natriuretic peptide in patients with acute coronary syn-dromes. N Engl J Med,2001,345: 1014-1021.
  • 7李静梅,高奋,肖传实.心肌梗死患者同型半胱氨酸与冠心病传统危险因素的比较[J].中国动脉硬化杂志,2001,9(2):137-139. 被引量:16
  • 8Antoniades,Alexios. Homocysteine and coronary atherosclerosis:from folate fortifieation to the recent clinical trials Charalambos.Eur Heart J,2009,30:6-15.
  • 9Wald DS,Law M,Morris JK. Homocysteine and cardiovasculardisease: evidence on causality from a meta-analysis. BMJ, 2002,325:1202-1206.
  • 10Mirdamadi A, Farzamnia H, Varzandeh P, et al. Associationbetween serum homocysteine concentration with coronary arterydisease in Iranian patients. Arya Atheroscler, 2011,7 (Summer):63-67.

二级参考文献2

  • 1Woo K S,Circulation,1997年,96卷,2542页
  • 2Glreck C J,Am J Cardiol,1995年,75卷,132页

共引文献27

同被引文献56

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部